Cherry Lab

Lab Team

  • Leah VandenBosch

    Leah VandenBosch

  • Stella Xu

    Stella Xu

Lab Alumni

Kelsey Luu

Research Student

Kelsey LuuKelsey Luu is now a student at Harvard Medical School pursing a master's in biomedical informatics. As a UW bioengineering undergraduate Kelsey performed research in our lab from 2017–2020. Her capstone thesis started a new direction for the lab: integrating machine learning and epigenomics to predict the impact of potentially disease-causing genetic variants on the retina. While in the lab, Kelsey was a two-time recipient of the Mary Gates Research Scholarship. She was also awarded the Bioengineering Undergraduate Scholarship and the Washington State Opportunity Scholarship.

Liesl Strand

Liesel StrandLiesl Strand is now a PhD candidate at Stanford University in the Department of Developmental Biology. Liesl was a research assistant in our lab from 2017–2019. Her research in the lab centered on the cooperative action of enhancers in the evolution and development of photoreceptor cells. She was invited to present this work at the annual Northwest Developmental Biology Symposium in 2019.

Nicole Mattson

Nicole MattsonNicole Mattson is currently a medical student at the University of Washington School of Medicine. Nicole pursued work in the lab centered on developing CRISPR-based viral gene therapy for Usher syndrome type II. For this work Nicole was awarded a Fight for Sight research fellowship and was invited to present her work at the Western Medical Research Conference in 2018.

Alex Neitz

Alex NeitzAlex Neitz is now a PhD candidate at the University of Washington in the Department of Biology. Alex rotated in the lab as an MCB graduate student during the summer of 2019. Her project in the lab was to compare the epigenomic landscape of the human retina and stem cell–derived organoids.

James Gillespie

James GillespieJames Gillespie is currently a medical student at the University of Washington School of Medicine. James made important contributions to our lab’s ongoing work on macular telangiectasia type 2 and genetic enhancer elements.